Mahajan Arjun, Barbieri John, Piette Evan
Harvard Medical School, Boston, MA, USA.
AMIA Jt Summits Transl Sci Proc. 2025 Jun 10;2025:350-354. eCollection 2025.
IgA Vasculitis (IgAV) is an immune-mediated condition with limited data on its long-term prognosis in adults. This study utilized the federated TriNetX network to evaluate the incidence of cardiac, renal, and vascular complications in adults diagnosed with IgAV. After propensity score matching, 12,506 patients with IgAV and 12,506 controls were analyzed. Over 6-month, 1-year, and 3-year periods, patients with IgAV had significantly higher risks of myocardial infarction, atrial fibrillation, stroke, pulmonary embolism, venous thromboembolism, chronic kidney disease, and end-stage renal disease compared to controls. Chronic kidney disease was the most common complication, with a 3-year risk of 8.6% and the highest absolute and relative risk difference. These findings suggest that adults with IgAV may be at increased risk for serious renal and cardiovascular complications, underscoring the need for further study to determine best practices for long term monitoring and management to mitigate morbidity associated with the disease.
IgA 血管炎(IgAV)是一种免疫介导的疾病,关于其在成人中的长期预后的数据有限。本研究利用联合的TriNetX网络来评估诊断为IgAV的成人发生心脏、肾脏和血管并发症的发生率。经过倾向评分匹配后,对12506例IgAV患者和12506例对照进行了分析。在6个月、1年和3年期间,与对照组相比,IgAV患者发生心肌梗死、心房颤动、中风、肺栓塞、静脉血栓栓塞、慢性肾脏病和终末期肾病的风险显著更高。慢性肾脏病是最常见的并发症,3年风险为8.6%,绝对和相对风险差异最高。这些发现表明,患有IgAV的成人可能发生严重肾脏和心血管并发症的风险增加,这突出了进一步研究以确定长期监测和管理的最佳做法以减轻与该疾病相关的发病率的必要性。